These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097 [TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases. Sun S; Zhang Z; Kodumuru V; Pokrovskaia N; Fonarev J; Jia Q; Leung PY; Tran J; Ratkay LG; McLaren DG; Radomski C; Chowdhury S; Fu J; Hubbard B; Winther MD; Dales NA Bioorg Med Chem Lett; 2014 Jan; 24(2):520-5. PubMed ID: 24374272 [TBL] [Abstract][Full Text] [Related]
7. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry. Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133 [TBL] [Abstract][Full Text] [Related]
8. Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Deng Y; Yang Z; Shipps GW; Lo SM; West R; Hwa J; Zheng S; Farley C; Lachowicz J; van Heek M; Bass AS; Sinha DP; Mahon CR; Cartwright ME Bioorg Med Chem Lett; 2013 Feb; 23(3):791-6. PubMed ID: 23265904 [TBL] [Abstract][Full Text] [Related]
9. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome. Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208 [TBL] [Abstract][Full Text] [Related]
10. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269 [TBL] [Abstract][Full Text] [Related]
11. Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors. Ramtohul YK; Powell D; Leclerc JP; Leger S; Oballa R; Black C; Isabel E; Li CS; Crane S; Robichaud J; Guay J; Guiral S; Zhang L; Huang Z Bioorg Med Chem Lett; 2011 Oct; 21(19):5692-6. PubMed ID: 21871798 [TBL] [Abstract][Full Text] [Related]
12. Tetrahydrobenzothiophene carboxamides: Beyond the kinase domain and into the fatty acid realm. Llona-Minguez S; Fayezi S; Alihemmati A; Juárez-Jiménez J; Piedrafita FJ; Helleday T Bioorg Med Chem Lett; 2017 Sep; 27(18):4462-4466. PubMed ID: 28807439 [TBL] [Abstract][Full Text] [Related]
13. Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1). Voss MD; Zoller G; Matter H; Herling AW; Biemer-Daub G; Pfenninger A; Haag-Diergarten S; Keil S; Kohlmann M; Schmidts HL Eur J Pharmacol; 2013 May; 707(1-3):140-6. PubMed ID: 23524088 [TBL] [Abstract][Full Text] [Related]
14. Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects. Sun S; Zhang Z; Raina V; Pokrovskaia N; Hou D; Namdari R; Khakh K; Ratkay LG; McLaren DG; Mork M; Fu J; Ferreira S; Hubbard B; Winther MD; Dales N Bioorg Med Chem Lett; 2014 Jan; 24(2):526-31. PubMed ID: 24370012 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents. Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972 [TBL] [Abstract][Full Text] [Related]